Dexamethasone could potentially soon be authorized for use in the EU for treating hospitalized adult patients with COVID-19, after the European Medicines Agency today said it had begun evaluating a marketing application for a product called Dexamethasone Taw for this purpose.
The application, submitted by the UK consultancy firm Taw Pharma on behalf of an unnamed drug company, is being reviewed...








